Boai Nky Pharmaceuticals Stock Shares Outstanding
| 300109 Stock | 14.79 0.19 1.27% |
Boai NKY Pharmaceuticals fundamentals help investors to digest information that contributes to Boai NKY's financial success or failures. It also enables traders to predict the movement of Boai Stock. The fundamental analysis module provides a way to measure Boai NKY's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Boai NKY stock.
As of December 4, 2024, Common Stock Shares Outstanding is expected to decline to about 217.8 M. Boai | Shares Outstanding |
Boai NKY Pharmaceuticals Company Shares Outstanding Analysis
Boai NKY's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Boai NKY Shares Outstanding | 484.7 M |
Most of Boai NKY's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Boai NKY Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Boai Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, Boai NKY Pharmaceuticals has 484.7 M of shares currently outstending. This is 168.48% higher than that of the Chemicals sector and significantly higher than that of the Materials industry. The shares outstanding for all China stocks is 15.24% higher than that of the company.
Boai Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Boai NKY's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Boai NKY could also be used in its relative valuation, which is a method of valuing Boai NKY by comparing valuation metrics of similar companies.Boai NKY is currently under evaluation in shares outstanding category among its peers.
Boai Fundamentals
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0651 | ||||
| Profit Margin | 0.27 % | ||||
| Operating Margin | 0.29 % | ||||
| Current Valuation | 7.34 B | ||||
| Shares Outstanding | 484.7 M | ||||
| Shares Owned By Insiders | 24.98 % | ||||
| Shares Owned By Institutions | 5.90 % | ||||
| Price To Book | 2.07 X | ||||
| Price To Sales | 4.89 X | ||||
| Revenue | 1.59 B | ||||
| Gross Profit | 690.63 M | ||||
| EBITDA | 671.45 M | ||||
| Net Income | 485.79 M | ||||
| Total Debt | 60.41 M | ||||
| Book Value Per Share | 7.23 X | ||||
| Cash Flow From Operations | 488.25 M | ||||
| Earnings Per Share | 0.79 X | ||||
| Target Price | 26.15 | ||||
| Number Of Employees | 1.17 K | ||||
| Beta | 0.12 | ||||
| Market Capitalization | 7.26 B | ||||
| Total Asset | 4.02 B | ||||
| Retained Earnings | 1.01 B | ||||
| Working Capital | 760.05 M | ||||
| Annual Yield | 0.07 % | ||||
| Net Asset | 4.02 B | ||||
| Last Dividend Paid | 0.67 |
About Boai NKY Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Boai NKY Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Boai NKY using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Boai NKY Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Boai Stock
Boai NKY financial ratios help investors to determine whether Boai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Boai with respect to the benefits of owning Boai NKY security.